Compound 60 has a very large affinity to MDM2 (Ki < one nM), potent cellular exercise, and a very good oral pharmacokinetic profile. Compound 60 is able to accomplishing entire and extended-Long lasting tumor regression in vivo and it is at this time in stage I medical trials for cancer https://nikitag297xdh1.nizarblog.com/profile